Word: whiteheaded
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Even more than aiming to attract talent, executives say they're focused on the bottom line. "Our investment is in keeping health-care costs down," says D'Ann Whitehead, preventive-health-services manager at Chevron. A study by the MEDSTAT Group consulting firm found that over the past eight years, Chevron had held medical expenses flat and slashed worker sick days by using everything from massage to smoking restrictions...
Until now. According to a report in the current issue of Nature, a team of scientists based at M.I.T.'s Whitehead Institute for Biomedical Research has finally managed to make human cells malignant--a feat they accomplished with two different cell types by inserting just three altered genes into their DNA. While these manipulations were done only in lab dishes and won't lead to any immediate treatment, they appear to be a crucial step in understanding the disease. This is a "landmark paper," wrote Jonathan Weitzman and Moshe Yaniv of the Pasteur Institute in Paris, in an accompanying commentary...
...dramatic new result traces back to a breakthrough in 1983, when the Whitehead's Robert Weinberg and colleagues showed that mouse cells would become cancerous when spiked with two altered genes. But when they tried such alterations on human cells, they didn't work. Since then, scientists have learned that mouse cells differ from human cells in an important respect: they have higher levels of an enzyme called telomerase. That enzyme keeps caplike structures called telomeres on the ends of chromosomes from getting shorter with each round of cell division. Such shortening is part of a cell's aging process...
...cells divide rapidly; another that disables two substances meant to rein in excessive division; and a third that promotes the production of telomerase, which made the cells essentially immortal. They'd created a tumor in a test tube. "Some people believed that telomerase wasn't that important," says the Whitehead's William Hahn, the study's lead author. "This allows us to say with some certainty that...
...differences between normal and malignant cells, doctors may someday be able to design tests to pick up cancer in its earliest stages. The finding could also lead to drugs tailored to attack specific types of cancer, thereby lessening our dependence on tissue-destroying chemotherapy and radiation. Beyond that, the Whitehead research suggests that this stubbornly complex disease may have a simple origin, and the identification of that origin may turn out to be the most important step...